Serum soluble triggering receptor expressed on myeloid cells‐2 was not altered by rTMS in patients with treatment‐resistant depression

• Main Authors: Hiroshi Tateishi (Author), Jun Matsushima (Author), Hiroko Kunitake (Author), Yoshiomi Imamura (Author), Yutaka Kunitake (Author), Toru Murakawa (Author), Seiji Mawatari (Author), Ryohei Kojima (Author), Yuka Fujii (Author), Jun Kikuchi (Author), Junko Fukuchi (Author), Yuta Sakemura (Author), Takumi Shiraishi (Author), Chika Nagahama (Author), Toshihiko Maekawa (Author), Toyoko Asami (Author), Yoshito Mizoguchi (Author), Akira Monji (Author)
• Format: Book
• Published: Wiley, 2023-06-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Abstract Aim Repetitive transcranial magnetic stimulation (rTMS) is one of the most effective and minimally invasive treatments for treatment‐resistant depression (TRD). However, the mechanism underlying the therapeutic effects of rTMS in patients with TRD remains unclear. In recent years, the patho...